Palvella Therapeutics, Inc.
- Last sale
- Nov 12, 2026 · -6.56%
- Market cap
- $2.24B
- 14.62M shares
- Filings
- 819
Q3 2024+65.3% FY23 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2024derivedN/M FY23 yoy
Q3 2026N/M FY25 yoy
Q3 2026−30.6% FY25 yoy
- $2.24B
- —
- —
- 11.3×
- —
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2023 | 2023-12-31 | $42,810,000 | reported | |
| FY 2022 | 2022-12-31 | $25,902,000 | reported | |
| FY 2021 | 2021-12-31 | $31,418,000 | reported | |
| FY 2020 | 2020-12-31 | $29,323,000 | reported | |
| FY 2019 | 2019-12-31 | $43,646,000 revised | reported | |
| FY 2018 | 2018-12-31 | $27,248,000 revised | reported | |
| FY 2017 | 2017-12-31 | $25,275,000 | reported | |
| FY 2016 | 2016-12-31 | $5,831,000 | reported | |
| FY 2015 | 2015-12-31 | $2,931,931 | reported | |
| FY 2014 | 2014-12-31 | $5,365,054 | reported | |
| FY 2013 | 2013-12-31 | $12,427,292 | reported |
Segments
Products
LineFY2019ShareChange
Customer revenue$32.07M69%—
Collaboration revenue$14.21M31%—
Total$46.28M
Pharmaceutical preparations
Palvella Therapeutics, Inc. is the 87th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
SDGRSchrodinger, Inc.$255.9M23.3%40.4%$2.3BPRGOPerrigo Co PLC$4.3B2.8%33.5%$2.2B
PVLAPalvella Therapeutics, Inc. (this company)———$2.2B
LKFTLakefront Biotherapeutics NV———$2.2BPHVSPharvaris N.V.Fiscal 2020 figures———$2.2BIMNMImmunome Inc.$6.9M23.2%3,060.0%$2.2BAUPHAurinia Pharmaceuticals Inc.$283.1M20.4%101.5%$2.2BPBHPrestige Consumer Healthcare Inc.$1.1B4.3%17.5%$2.1BVERAVera Therapeutics, Inc.———$2.1BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Palvella Therapeutics, Inc. · CIK 1583648 · Engraved from SEC EDGAR